jl – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 22 Results  www.cadth.ca
  Issue 10 | CADTH  
145. Wang K, Yorke E, Nehmeh SA, Humm JL, Ling CC. Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET. Med Phys.
Drubach LA, Sapp MV, Laffin S, Kleinman PK. Fluorine-18 NaF PET imaging of child abuse. Pediatr Radiol.
  An analysis of the use ...  
Cite as: Glennie JL. An analysis of the use of fuoroquinolones for uncomplicated urinary tract infections, prostatitis, and CAP. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997.
Citer le présent document comme suit: Glennie JL. Considérations d’ordre clinique et économique sur l’emploi des fluoroquinolones. Ottawa: Office canadien de coordination de l'évaluation des technologies de la santé (OCCETS); 1998.
  Pharmacoeconomic evalua...  
Cite as: Glennie JL. Pharmacoeconomic evaluations of clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997.
Citer le présent document comme suit: Glennie JL. Évaluation pharmacoéconomique de la clozapine dans le traitement de la schizophrénie réfractaire et de la rispéridone dans le traitement de la schizophrénie chronique.Ottawa: Office canadien de coordination de l'évaluation des technologies de la santé (OCCETS); 1997
  Antithrombotic Agents f...  
43. Fox KA, Piccini JP, Wojdyla D, Becker RC, Halperin JL, Nessel CC, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
Fox KA, Piccini JP, Wojdyla D, Becker RC, Halperin JL, Nessel CC, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J [Internet].
  The efficacy of tacrine...  
Cite as: Glennie JL. The efficacy of tacrine and the measurement of outcomes in Alzheimer's disease. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997.
Citer le présent document comme suit: Glennie JL. Efficacité de la tacrine et mesure des résultats thérapeutiques dans la maladie d'Alzheimer. Ottawa: Office canadien de coordination de l'évaluation des technologies de la santé (OCCETS); 1997.
  Clopidogrel versus Othe...  
Adapted from Banerjee S, Brown A, McGahan L, Asakawa K, Hutton B, Clark M, Severn M, Sharma M, Cox JL.
Adaptation de Banerjee S, Brown A, McGahan L, Asakawa K, Hutton B, Clark M, Severn M, Sharma M, Cox JL.
  Policy Perspectives on ...  
Hivon M, Lehoux P, Denis JL, Tailliez S. Use of health technology assessment in decision making: coresponsibility of users and producers?
11. Daniels S, Ramey M. The leader's guide to hospital case management. Sudbury (MA): Jones and Bartlett Publishers; 2005.
  Clinical and economic c...  
Cite as: Glennie JL. Clinical and economic considerations in the use of fluoroquinolones. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997.
Citer le présent document comme suit: Glennie JL. Considérations d' ordre clinique et économique sur l' emploi des fluoroquinolones. Ottawa: Office canadien de coordination de l'évaluation des technologies de la santé (OCCETS); 1998.